Evaluation of Plasma Biomarker Utility for the Gastrointestinal Acute Radiation Syndrome in Non-human Primates After Partial Body Irradiation with Minimal Bone Marrow Sparing Through Correlation with Tissue and Histological Analyses
Overview
Nuclear Medicine
Authors
Affiliations
Exposure to total- and partial-body irradiation following a nuclear or radiological incident result in the potentially lethal acute radiation syndromes of the gastrointestinal and hematopoietic systems in a dose- and time-dependent manner. Radiation-induced damage to the gastrointestinal tract is observed within days to weeks post-irradiation. Our objective in this study was to evaluate plasma biomarker utility for the gastrointestinal acute radiation syndrome in non-human primates after partial body irradiation with minimal bone marrow sparing through correlation with tissue and histological analyses. Plasma and jejunum samples from non-human primates exposed to partial body irradiation of 12 Gy with bone marrow sparing of 2.5% were evaluated at various time points from day 0 to day 21 as part of a natural history study. Additionally, longitudinal plasma samples from non-human primates exposed to 10 Gy partial body irradiation with 2.5% bone marrow sparing were evaluated at timepoints out to 180 d post-irradiation. Plasma and jejunum metabolites were quantified via liquid chromatography-tandem mass spectrometry and histological analysis consisted of corrected crypt number, an established metric to assess radiation-induced gastrointestinal damage. A positive correlation of metabolite levels in jejunum and plasma was observed for citrulline, serotonin, acylcarnitine, and multiple species of phosphatidylcholines. Citrulline levels also correlated with injury and regeneration of crypts in the small intestine. These results expand the characterization of the natural history of gastrointestinal acute radiation syndrome in non-human primates exposed to partial body irradiation with minimal bone marrow sparing and also provide additional data toward the correlation of citrulline with histological endpoints.
Metabolomics identifies plasma biomarkers of localized radiation injury.
Ancel L, Grison S, Gabillot O, Gueguen J, Svilar L, Guen B Sci Rep. 2025; 15(1):2166.
PMID: 39819895 PMC: 11739571. DOI: 10.1038/s41598-025-85717-5.
Gastrointestinal Acute Radiation Syndrome: Mechanisms, Models, Markers, and Medical Countermeasures.
Winters T, Marzella L, Molinar-Inglis O, Price P, Han N, Cohen J Radiat Res. 2024; 201(6):628-646.
PMID: 38616048 PMC: 11658916. DOI: 10.1667/RADE-23-00196.1.
Radiation-induced multi-organ injury.
Molinar-Inglis O, DiCarlo A, Lapinskas P, Rios C, Satyamitra M, Silverman T Int J Radiat Biol. 2024; 100(3):486-504.
PMID: 38166195 PMC: 11874064. DOI: 10.1080/09553002.2023.2295298.
Garg S, Garg T, Miousse I, Wise S, Fatanmi O, Savenka A Antioxidants (Basel). 2022; 11(10).
PMID: 36290618 PMC: 9598988. DOI: 10.3390/antiox11101895.
Satyamitra M, DiCarlo A, Hollingsworth B, Winters T, Taliaferro L Radiat Res. 2021; 197(5):514-532.
PMID: 34879151 PMC: 9119904. DOI: 10.1667/RADE-21-00157.1.